Targeted sequencing of a HNSCC patient tumor
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Next generation sequencing of a HNSCC patient's recurrent tumor for 244 genes known to be somatically altered in HNSCC revealed a non-canonical PIK3CA mutation. The patient was enrolled in the TRIUMPH trial and assigned to receive alpelisib monotherapy based on detection of the PIK3CA mutation in his tumor.
创建时间：
2021-09-17
